Is the treatment listed below routinely available to patients according to it’s NICE TAG?
Please could you indicate by putting a cross in the applicable box below and sending the completed table back to RNIB (contact details below). Confirmation (i.e. indicating ‘yes’) means that patients do not have to use Individual Funding Requests to access aflibercept for treating choroidal neovascularisation.
Please put a cross in the relevant box:
|
||
|
|
Yes |
No |
|
Aflibercept for treating choroidal neovascularisation Technology appraisal guidance [TA486] Published date: 01 November 2017 |
X |
|
